I hope those people in the management will go away soon. SPPI has devalued in price
despite the fact that there are new drugs that are coming out in the pipeline. Raj and his
lieutenants have given themselves nice salaries, bonuses and stock options and
golden parachute to the detriment of the stockholders. I hope they find a buyer to buy
SPPI soon. I think that is what they are doing right now, that is why they have this
golden parachute on hand if they are terminated.
I hope Raj is looking for a buyer of SPPI Market value of the company will never improve as long as he is in the helm.
There is nothing to celebrate at this point coz this is not a new high. Until it gets over $16, maybe there is something to cheer about and if it hits $20 when results of VGX 3100 is announced, maybe time to pop
Sentiment: Strong Buy
This stock is a disappointment and frustrating for all long holders like me. Raj has either find a buyer for this company or quit and find a new CEO that could execute.
Raj and the board has to go. SPPI will never get its true value unless Ray and the board are replaced.
The constant bashing from the The Street and SA are keeping this stock down.
There should be a complete overhaul of the top management and board of directors that will give new directions to SPPI that will give value to the company. Raj has done a good job in building up
SPPI's drug pipeline but never gotten the respect of wall st.to increase the value of SPPI.
Raj and his lieutenants have fatten their pockets in salaries and options to the detriment of
investors. I hope the board and management are listening or reading our blogs.
If this is true that belviq lowers A1c levels of diabetic people then more doctors will be prescribing
belviq for all those obese people. Maybe Eisai will have an incentive to buy ARNA now.
I'm all for a buy-out, It's been a rough 1 1/2 years since the FDA approved belviq, the value of
ARNA has gone south with the delayed classification from the DEA.
Like everybody else, I'm totally disgusted with this. SPPI is generating revenue and has many drugs in the pipeline yet the price of the stock is nowhere to be compared with other bio-pharmas. This totally ridiculous.
A paltry .18 cents increase. If the name is other than SPPI, this could have gone up more than a $1with this fast track news.
Raj is making too much money in terms of salary and options along with his lieutenants. Nobody likes to
hold SPPI long. This is just good for day trading.
There is no trust in Raj and his lieutenants at this time. Even if SPPI exceeds Q1 it will hardly move up
because of distrust on management and also the constant bashing from The Street. It has been frustrating
for us longs to see this stock going nowhere.
If the name is not SPPI, I think it is well in that range of $12-15 but because of Raj and the frequent bashing
of A. #$%$stein and The Street this stock is in a reverse mode. Retail investors like us are forever disappointed.
We keep on waiting and waiting that soon SPPI will go up but it never happens.
Time for the management to look for alternative and that is to sell the company to Eisai. The retail investors
that bought shares when the price of ARNA was at its highest are getting nowhere and this will take
forever to recoup their investment.
It appears that every time there is some good news from SPPI, the share price spikes up momentarily and
then comes down right away. It seems like SPPI has some kind erectile dysfunction, it does not stay up
for long. Does anybody think it is all about Raj?
I bet you Adam F. will recycle his article that he posted when INO did the R/S and everyone did a sell off and
the following day someone on The Street posted an article putting a buy order on INO, just a complete
manipulation by The Street people and Jim Cramer.
Anybody who listens to these people are being fooled.
I think everybody share your sentiment. New CEO and a new BOD that will give new direction to this
company with too many approved drugs but have been underperforming. Management is only concerned
with their salaries and options instead of creating values to the company.
Every time some small bio tech stocks are moving up, Adam F. recycles his old articles to slam the upward moves of these bio techs. I think Adam F. is a cancer to small bio tech companies making sure that they
don't have a chance to move up higher no matter how noble their drugs are.
Management should find a buyer. They don't know how to market lymphoseek. I will be happy if I could get it
back $3.50/share on this one.
He should sell ARNA to Eisai. $15 is ok with me considering there are a lot of obese people in the world
and sales of Belviq has been a disappointment. Maybe if Eisai fully owns ARNA, sales will boom.
Raj is rally milking this company for his own pocket and his top lieutenants. He should just sell the company and retire. SPPI has lost value for the last 2 1/2 years. Its time for him to go.